Therapy reduction in patients with Down syndrome and myeloid leukemia: the international ML-DS 2006 trial. [electronic resource]
Producer: 20170828Description: 3314-3321 p. digitalISSN:- 1528-0020
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Child, Preschool
- Chromosomes, Human, Pair 8 -- genetics
- Cytarabine -- adverse effects
- Cytogenetic Analysis
- Disease-Free Survival
- Down Syndrome -- complications
- Etoposide -- adverse effects
- Female
- Humans
- Idarubicin -- adverse effects
- Infant
- Leukemia, Myeloid -- complications
- Male
- Prospective Studies
- Treatment Outcome
- Trisomy -- genetics
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.